SAURABH SAHA, CEO, Director at Centessa Pharmaceuticals, holds 82.02K shares in Clarivate (Ticker: CLVT), holds 369.02K shares in Centessa Pharmaceuticals (Ticker: CNTA). Most recently, SAURABH SAHA Bought ― shares of Clarivate on Mar 05, 2025 for an estimated value of 254.08K.
What is the percentage of profitable transactions made by SAURABH SAHA?
The percentage of profitable transactions made by SAURABH SAHA is 60%.
What is the average return per transaction made by SAURABH SAHA?
The average return per transaction made by SAURABH SAHA is -11.30%.
What stocks does SAURABH SAHA hold?
SAURABH SAHA holds: CNTA, CLVT stocks.
What was SAURABH SAHA’s latest transaction?
SAURABH SAHA latest transaction was an Informative Buy of $254.08K.
What was SAURABH SAHA's most profitable transaction?
SAURABH SAHA’s most profitable transaction was an Informative Sell of CLVT stock on September 4, 2024. The return on the trade was 39.10%.
What is SAURABH SAHA's role in Centessa Pharmaceuticals?
SAURABH SAHA's role in Centessa Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.